Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to test the value of immediate post-operative intravesical
instillation of epirubicin in patients with intermediate and high risk non muscle invasive
bladder cancer (NMIBC).